OLIPASS CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 531 KRW | -6.18% |
|
-7.97% | -31.40% |
| 29/05 | OLIPASS Corporation announced that it has received KRW 2.501 billion in funding | CI |
| 18/03 | OLIPASS Corporation announced that it has received KRW 3.5 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.33Cr | - | - | - | - | - | |
| 12TCr | ||||||
| 11TCr | ||||||
| 2.59TCr | - | |||||
| 2.09TCr | - | |||||
| 1.68TCr | - |
